Combination therapy using transferrin fusion proteins comprising GLP-1

Details for Australian Patent Application No. 2005271403 (hide)

Owner Biorexis Pharmaceutical Corporation

Inventors Prior, Christopher; Sadeghi, Homayoun; Balance, David J.

Agent Allens Arthur Robinson

Pub. Number AU-A-2005271403

PCT Pub. Number WO2006/017688

Priority 60/598,031 03.08.04 US

Filing date 3 August 2005

Wipo publication date 16 February 2006

International Classifications

A61K 38/26 (2006.01) Medicinal preparations containing peptides - Glucagons

Event Publications

22 February 2007 PCT application entered the National Phase

  PCT publication WO2006/017688 Priority application(s): WO2006/017688

2 July 2009 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005271407-Novel fenofibrate formulations and related methods of treatment

2005271399-Portable isolation enclosure